A Bull Market Continues To Unfold On Walgreens Boots Alliance Inc (NASDAQ: WBA), As It Continued To Rise 21.70% In Year-To-Date

During the recent session, Walgreens Boots Alliance Inc (NASDAQ:WBA)’s traded shares were 55.07 million, with the beta value of the company hitting 0.69. At the last check today, the stock’s price was $11.35, reflecting an intraday gain of 7.12% or $0.75. The 52-week high for the WBA share is $22.05, that puts it down -94.27 from that peak though still a striking 28.81% gain since the share price plummeted to a 52-week low of $8.08. The company’s market capitalization is $9.81B, and the average trade volume was 27.27 million shares over the past three months.

Walgreens Boots Alliance Inc (WBA) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 2.82. WBA has a Sell rating from 1 analyst(s) out of 11 analysts who have looked at this stock. 6 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.52.

Walgreens Boots Alliance Inc (NASDAQ:WBA) trade information

Walgreens Boots Alliance Inc (WBA) registered a 7.12% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 7.12% in intraday trading to $11.35, hitting a weekly high. The stock’s 5-day price performance is 6.32%, and it has moved by 12.20% in 30 days. Based on these gigs, the overall price performance for the year is -45.95%.

The consensus price target of analysts on Wall Street is $10, which implies a decrease of -13.5% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9 and $12 respectively. As a result, WBA is trading at a discount of -5.73% off the target high and 20.7% off the low.

Walgreens Boots Alliance Inc (WBA) estimates and forecasts

In the rating firms’ projections, revenue will increase 2.69% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 37.9B as predicted by 10 analyst(s). Meanwhile, a consensus of 10 analyst(s) estimates revenue growth to 36.96B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 37.05B and 36.35B respectively. In this case, analysts expect current quarter sales to grow by 2.30% and then jump by 1.69% in the coming quarter.

While earnings are projected to return -43.80% in 2025, the next five years will return -16.28% per annum.

WBA Dividends

Walgreens Boots Alliance Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Walgreens Boots Alliance Inc is 0.75, with the dividend yield indicating at 6.61 percent, continuing the trend of increasing dividends in recent years.

Walgreens Boots Alliance Inc (NASDAQ:WBA)’s Major holders

The next largest institutional holding, with 70.01 million shares, is of BLACKROCK INC.’s that is approximately 8.1114% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $846.76 million.

Also, the Mutual Funds coming in first place with the largest holdings of Walgreens Boots Alliance Inc (WBA) shares are Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 21.86 shares. This amounts to just over 2.53 percent of the company’s overall shares, with a $248.18 million market value. The same data shows that the other fund manager holds slightly less at 19.42, or about 2.25% of the stock, which is worth about $220.54 million.